DPCA uncovers tax evasion in import of cancer drug
KARACHI: A case of tax evasion in import of cancer drug named “Tasigna” has been uncovered by Directorate of Post-Clearance Audit (DPCA).
According...
LCCI demands DRAP to form a liaison committee
LAHORE: The Lahore Chamber of Commerce and Industry (LCCI) has demanded from the Drug Regulatory Authority of Pakistan (DRAP) to form a...
PPMA vs DRAP: Pharma crisis continues
Unavailability of medicines could inevitably trigger national health emergency
Law ministry advises govt against notifying drug price increases
ISLAMABAD: The government has been told to withhold a drug price revision notification by the Law Division regarding change in prices of...
The mechanics behind the panadol shortage
Raids, hoarding and over regulating — You probably need a Panadol to figure out what’s going on
Pharma has potential to surpass textile industry in Pakistan: Chairman AGP
KARACHI: The pharmaceutical industry in Pakistan has the potential to increase its exports to such an extent that it can become the biggest...
Pakistan’s biggest pharma deal in advanced talks: report
Businessman Munis Abdulla to purchase one of OBS Group's pharmaceutical operations for a reported sum of Rs11bn
Pakistan's OBS Group is in...
Pharma industry decides to slash prices of 395 essential drugs
'Prices will not increase if rupee remains stabilised, utility prices are maintained and rate of inflation is controlled'
KARACHI: Pakistan Pharmaceutical Manufacturers' Association...
OBS Pakistan amalgamates AGP with AitkenStuart
It is pertinent to mention that rumours had been circulating that OBS Pakistan was going through major restructuring and this acquisition by Searle comes as a surprise for the market.
UK report claims Pakistan’s Covid-19 medicine enough for national demand
Pakistan, along with India, is the only one among developing countries to have effectively stored enough of Remdesivir to meet their national...
Pfizer looks beyond COVID sales with $43b deal for cancer drugmaker Seagen
WASHNGTON: Pfizer Inc on Monday struck a roughly $43 billion deal for Seagen Inc to bulk up its cancer treatments portfolio, as...
Can Hamdard thrive in the era of the millennial consumer?
It is an ad that relies on contrasts: a product as traditionally Pakistani as Hamdard’s Rooh Afza being consumed by non-Pakistanis in...
Pricing dispute causes shortage of critical medicine
Pharma companies stop, limit production of scores of essential and non-essential medicines as govt rejects demand for 38% hike in prices
Pharmaceuticals in Pakistan: extracting whatever they can from the pie
Can the pharmaceutical sector ever be reformed? Kabeer Dawani and Asad Sayeed take a look at the sector’s pitfalls, and ways forward.
Govt decision to increase medicine prices augurs well for domestic drugmakers: Fitch Solutions
Revenue generating opportunities for local pharmaceutical companies in Pakistan will improve following the decision by the government to increase the prices of medicines, said Fitch Solutions